Common Contracts

EXECUTION VERSION PURCHASE AGREEMENT by and between ONCOBIOLOGICS, Inc. and GMS TENSHI HOLDINGS PTE. LIMITED Dated September 7, 2017 Page

Purchase Agreement • May 5th, 2020 • New York

• Contract Type
  Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

PURCHASE AGREEMENT by and between ONCOBIOLOGICS, Inc. and BIOLEXIS PTE. LIMITED Dated November 5, 2018

Purchase Agreement • November 9th, 2018 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Purchase Agreement
• Filed
  November 9th, 2018
• Company
  Oncobiologics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This PURCHASE AGREEMENT (this “Agreement”), dated as of November 5, 2018, is entered into by and between Oncobiologics, Inc., a Delaware corporation (the “Company”), and BioLexis Pte. Limited, a Singapore private limited company (“Investor”).

PURCHASE AGREEMENT by and between ONCOBIOLOGICS, Inc. and GMS TENSHI HOLDINGS PTE. LIMITED Dated May 11, 2018

Purchase Agreement • May 15th, 2018 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Purchase Agreement
• Filed
  May 15th, 2018
• Company
  Oncobiologics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This PURCHASE AGREEMENT (this “Agreement”), dated as of May 11, 2018, is entered into by and between Oncobiologics, Inc., a Delaware corporation (the “Company”), and GMS Tenshi Holdings Pte. Limited, a Singapore private limited company (“Investor”).

PURCHASE AGREEMENT by and between ONCOBIOLOGICS, Inc. and GMS TENSHI HOLDINGS PTE. LIMITED Dated September 7, 2017

Purchase Agreement • September 11th, 2017 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Purchase Agreement
• Filed
  September 11th, 2017
• Company
  Oncobiologics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This PURCHASE AGREEMENT (this “Agreement”), dated as of September 7, 2017, is entered into by and between Oncobiologics, Inc., a Delaware corporation (the “Company”), and GMS Tenshi Holdings Pte. Limited, a Singapore private limited company (“Investor”).